[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:acral-melanoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Acral Melanoma",3,[7,14,21],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT06673095","Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial",[],"RECRUITING","2026-08-26T02:15:17.167444Z","2026-05-05T02:43:29.531334Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT07155317","Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial",[18],"Phase 2","2026-08-26T02:17:43.321968Z","2026-05-05T02:43:27.602103Z",{"nct_id":22,"title":23,"phases":24,"status":11,"updated_at":26,"content_modified":27},"NCT06021626","A Study of CRD3874-SI in People With Solid Tumors",[25],"Phase 1","2026-08-26T02:16:32.589113Z","2026-07-05T05:32:16.744495Z",[],[]]